Streetbeat News

PBLA

Panbela Therapeutics Inc.

http://www.sunbiopharma.com/

CEO

Michael Cullen

Open

0.32

Mkt cap

1.6M

Volume

6.3K

High

0.33

P/E Ratio

N/A

52-wk high

38.00

Low

0.32

Div yield

N/A

52-wk low

0.30

In Monday's intraday session, several healthcare stocks experienced significant movements. OneMedNet (ONMD) saw a 175.1% increase, while Palisade Bio (PALI) and NexImmune (NEXI) rose by 106.48% and 84.48%, respectively. FibroGen (FGEN), Atreca (BCEL), and Vivos Therapeutics (VVOS) also posted gains. Conversely, Panbela Therapeutics (PBLA), Processa Pharma (PCSA), Bullfrog AI Hldgs (BFRG), Inspire Veterinary (IVP), Corbus Pharmaceuticals (CRBP), and TC BioPharm (TCBP) experienced declines.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 5:31 pm

U.S. stocks traded mixed with the Dow slightly down and the Nasdaq up. Consumer discretionary shares rose, while energy shares fell. Palisade Bio surged after withdrawing a registration statement and announcing preclinical data. SoFi Technologies jumped on strong quarterly revenue. Cardlytics gained after a settlement agreement and updated Q4 results. Panbela Therapeutics plunged following a public offering announcement. Bullfrog AI fell after a shelf offering, and Bloom Energy dropped after a downgrade. Oil prices decreased, while gold and silver rose.

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 5:16 pm

U.S. stocks saw a slight increase with the Dow Jones gaining around 25 points. Amazon (AMZN) and iRobot (IRBT) mutually agreed to terminate their $1.7 billion merger deal, which would have allowed Amazon to invest in iRobot's innovation and support in reducing product prices. Other stocks mentioned include Palisade Bio (PALI), OneMedNet Corporation (ONMD), Revelation Biosciences (REVB), Panbela Therapeutics (PBLA), Arrival (ARVL), and SMX (Security Matters) Public Limited Company (SMX), with varying degrees of price movements.

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 2:48 pm

Panbela Therapeutics has announced the pricing of a public offering amounting to approximately $9 million, which has led to its shares trading lower.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:19 pm

In Monday's pre-market session, several healthcare stocks experienced significant movements. OneMedNet (ONMD) saw a substantial increase of 172.1%, while Panbela Therapeutics (PBLA) faced a sharp decline of 62.5%. Other notable gainers include Jin Medical International (ZJYL), NovaBay Pharmaceuticals (NBY), Longeveron (LGVN), Palisade Bio (PALI), and Science 37 Hldgs (SNCE). Conversely, Aclarion (ACON), HOOKIPA Pharma (HOOK), Onconetix (ONCO), Elicio Therapeutics (ELTX), and Checkpoint Therapeutics (CKPT) were among the losers.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 1:06 pm

ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) shares increased by 9.2% in pre-market trading following an upgrade from Hold to Buy by Jefferies, with a raised price target from $14 to $20. Other stocks also showed significant movement in pre-market trading, with various companies experiencing gains and losses. Notable gainers include NovaBay Pharmaceuticals, Inc. (NYSE:NBY) and Spectral AI, Inc. (NASDAQ:MDAI), while significant losers include Panbela Therapeutics, Inc. (NASDAQ:PBLA) and Aeva Technologies, Inc. (NYSE:AEVA).

Portfolio Pulse from Avi Kapoor

January 29, 2024 | 12:56 pm

Panbela Therapeutics has announced a public offering priced at $9 million. The offering includes 4.375 million common shares or pre-funded warrants, along with two classes of warrants to purchase up to 8.75 million shares at $2.06 per share and associated warrants.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 11:17 am

In Friday's after-market session, several healthcare stocks experienced significant movements. Palisade Bio (PALI) saw a 66% increase, while Aptorum Gr (APM) rose by 18.88%. NovaBay Pharmaceuticals (NBY), MyMD Pharmaceuticals (MYMD), NuCana (NCNA), and Asensus Surgical (ASXC) also posted gains. Conversely, Acutus Medical (AFIB), Aclarion (ACON), Inspire Veterinary (IVP), HeartBeam (BEAT), Panbela Therapeutics (PBLA), and AquaBounty Techs (AQB) experienced declines.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:31 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. Corbus Pharmaceuticals (CRBP) saw a massive increase of 309.1%, while Aclarion (ACON) rose by 67.82%. Inspire Veterinary (IVP), Panbela Therapeutics (PBLA), Inhibikase Therapeutics (IKT), and Vera Therapeutics (VERA) also posted gains. Conversely, Onconetix (ONCO), Processa Pharma (PCSA), Evaxion Biotech (EVAX), Jin Medical International (ZJYL), Acutus Medical (AFIB), and TC BioPharm (TCBP) experienced declines, with ONCO leading the losses at 33.7%.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 5:31 pm

Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares surged on heavy trading volume, significantly exceeding its 100-day average. The spike follows the company's announcement of reaching 50% enrollment for its Aspire global clinical trial for metastatic pancreatic cancer treatment. The small float of 480,324 shares post a 1-for-20 reverse split may also be amplifying the stock's movement.

Portfolio Pulse from Erica Kollmann

January 26, 2024 | 4:01 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.